Skip to content

Effect of 27g vitrectomy on ocular surface

Effect of 27g vitrectomy on ocular surface

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044136
Enrollment
Unknown
Registered
2021-03-11
Start date
2021-03-11
Completion date
Unknown
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After vitrectomy

Interventions

1:HYCOSAN
2:Diquafosol Sodium Eye Drops
Non intervention:none

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years. 2. Men and women are not limited. 3. 27g vitrectomy is needed. 4. It can ensure the preoperative and postoperative ocular surface analysis and lipiview examination. 5. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Aged older than 80 years; 2. Patients with systemic immune diseases; 3. Active eye infection; 4. Eye surgery within three months; 5. Participated in other clinical trials within 4 weeks before the start of this study; 6. This drug or other dry eye drugs were used in 3 months before the trial; 7. Known adverse reactions to Hailu or Rieth; 8. Glaucoma with high intraocular pressure or definite diagnosis (including steroid glaucoma); 9. Pregnant or lactating women; 10. Suspected or confirmed infectious lesions around the eyes (herpes simplex virus, varicella zoster virus, bacterial infection, fungal infection, etc.); 11. Previous congenital eye abnormalities; 12. History of ocular trauma; 13. Patients with eye diseases that have seriously affected vision in the past; 14. Have mental history.

Design outcomes

Secondary

MeasureTime frame
Intraocular pressure;

Primary

MeasureTime frame
Visual acuity;Ocular surface analyzer;LipiView;Schirmer I Test;Ocular surface disease index;

Countries

China

Contacts

Public ContactShao Yan

Tianjin Medical University Eye Hospital

sytmueh@163.com+86 17622651170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026